Journey Medical Corp (DERM) — Cash Flow Reinvestment Rate
Journey Medical Corp (DERM) has a Cash Flow Reinvestment Rate of 6.74x as of December 2024, reinvesting $15.00 Million (capex $0.00 plus investments $-15.00 Million) from operating cash flow of $2.23 Million. Check Journey Medical Corp cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Journey Medical Corp Cash Flow Reinvestment Rate (2019–2023)
Historical reinvestment intensity for Journey Medical Corp across 3 annual periods. Explore DERM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Journey Medical Corp (2019–2023)
Year-by-year capital reinvestment analysis for Journey Medical Corp. For live market cap and broader valuation context, see Journey Medical Corp (DERM) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.91x | $10.00 Million | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.47x | $2.40 Million | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.53x | $4.80 Million | $9.02 Million | $2.40 Million | — |